ArticleWorld journal of pediatrics : WJP2026
Regional and national burden of attention-deficit hyperactivity disorder in Asia, 1990-2023: a Global Burden of Disease Study 2023.
Article in World journal of pediatrics : WJP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundAttention-deficit hyperactivity disorder (ADHD) represents a substantial lifelong economic and functional burden, yet comprehensive assessments of its burden in Asia have been limited. In this study, we quantified the burden of ADHD across Asia at both regional and national levels.
methodsWe estimated the burden of ADHD across 34 Asian countries from 1990 to 2023 using data from the Global Burden of Disease Study 2023. ADHD was defined as the presence of six or more inattention or hyperactivity-impulsivity symptoms lasting ≥ 6 months. Burden was assessed using age-standardized years lived with disability (YLD) rates with 95% uncertainty intervals (UIs), stratified by age and sex, and compared across pre- and post-pandemic periods.
resultsThe burden of ADHD in Asia remained largely concentrated in childhood and adolescence, with comparatively modest temporal changes in age-standardized YLD rates from 1990 to 2023. East Asia showed the largest increase over this period and had the highest age-standardized YLD rate in 2023, at 82.20 (95% UI: 46.77-122.88) per 100,000 population. Across all Asian regions, age-specific YLD rates peaked among individuals aged 10 to 14 years, reaching 213.03 (95% UI: 113.82-322.27) per 100,000 population in East Asia, and declined progressively thereafter. Males consistently had higher YLD rates than females across regions and age groups. During the COVID-19 pandemic, the ADHD burden increased in most Asian countries, with particularly pronounced increases in the high-income Asia Pacific region. In addition, the ADHD burden was positively correlated with a higher Socio-demographic Index.
conclusionsOur findings define males and children aged 10-14 years as priority groups for early ADHD detection and intervention. Moreover, we provide critical evidence to guide targeted ADHD prevention and management strategies across Asia.
Indexed as
Identifiers
42853455What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.